Document is current
Any future updates will be listed below
-
Authors
Nakano, Yoshihisa
Adachi, Shiro
Hirose, Miku
Adachi, Takeshi
Nishiyama, Itsumure
Yasuda, Kenichiro
Yoshida, Masahiro
Kondo, Takahisa
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 11 August 2024
Accepted: 26 September 2024
First Online: 28 October 2024
Declarations
:
: Yoshihisa Nakano reports receiving speaker and lecturer fees from Bayer, Janssen Pharmaceutical, Nippon Shinyaku, and Viatris outside the submitted work. In addition, english proofreading and article processing charges were subsidized by Adempas Post Marketing Surveillance by Bayer. Shiro Adachi reports receiving speaker and lecturer fee from Bayer, Bristol Myers Squibb, Daiichi-Sankyo, Janssen Pharmaceutical, Mochida Pharmaceutical, Nippon Shinyaku, Pfizer, and Viatris outside the submitted work. Toyoaki Murohara reports receiving speaker and lecturer fee from Bayer, Daiichi-Sankyo, and Janssen Pharmaceutical outside the submitted work. Takahisa Kondo reports receiving speaker and lecturer fee from Bayer, Bristol Myers Squibb, Daiichi-Sankyo, Janssen Pharmaceutical, Nippon Shinyaku, and Pfizer outside the submitted work. All of the other authors declare that they have no conflicts of interest to disclose.
: This study was approved by the Human Research Ethics Committee of Nagoya University Hospital (no. 2020 − 0615).
